Form 4 for SER Serina Therapeutics, Inc.
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-20 · accession 0001301120-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-21 | 2026-01-20+ | SER | Moreadith Randall | CSO | M - OptEx | $0.06 | +4,000 | 2,000 | New | +$240 |
| DM | 2026-01-21 | 2026-01-20+ | SER | Moreadith Randall | CSO | S - Sale+OE | $3.04 | -4,000 | 0 | -100% | -$12.1K |
| DM | 2026-01-21 | 2026-01-20+ | SER | Moreadith Randall | CSO | M - OptEx | $0.00 | -4,000 | 328.7K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-20 | M | A | 2,000 | $0.06 | 2,000 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-20 | S | D | 2,000 | $3.07 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-21 | S | D | 2,000 | $3.00 | 0 | D | — | — | |
| 4 | Common | Common Stock | 2026-01-21 | M | A | 2,000 | $0.06 | 2,000 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2026-01-20 | M | D | 2,000 | $0.00 | 330,686 | D | $0.06 · — to 2031-05-06 | 2,000 Common Stock | (F1) The stock options are fully vested. |
| 6 | Derivative | Stock Option (right to buy) | 2026-01-21 | M | D | 2,000 | $0.00 | 328,686 | D | $0.06 · — to 2031-05-06 | 2,000 Common Stock | (F1) The stock options are fully vested. |